Shareholder Meeting - Form 8-K

Item 5.08 Shareholder Director Nominations.

On March 27 2024, Enveric Biosciences, Inc. (the "Company") scheduled the Company's 2024 Annual Meeting of Stockholders (the "Annual Meeting") for May 28, 2024, which date is more than 30 days from the first anniversary of the date of the Company's 2023 Annual Meeting of Stockholders that was held on November 2, 2023.

Stockholders may submit proposals on matters appropriate for stockholder action, including director nominations, at our annual meetings consistent with regulations adopted by the U.S. Securities and Exchange Commission (the "SEC") and the Company's bylaws. Because the date of the Annual Meeting is more than 30 days from the first anniversary of the date of the 2023 meeting, such stockholder proposals must be received by the Company within a reasonable time before the Company begins to print and send proxy materials for the Annual Meeting. In order to be considered timely, stockholder proposals to be considered for inclusion in the Company's proxy statement and proxy card relating to the Annual Meeting must have been received by the Company no later than April 8, 2024 at 5:00 Eastern time. Any such proposal must have also met the requirements set forth in the Company's bylaws and the rules and regulations of the SEC in order to be eligible for inclusion in the proxy materials for the Annual Meeting.